INTERVIEW: MAP Diagnostics pushes urine-based noninvasive prenatal Down syndrome test
This article was originally published in Clinica
Executive Summary
For a long time, screening for Down syndrome during pregnancy has left a lot to be desired. The current standard of care involves several blood tests and an ultrasound scan – women whose pregnancies are deemed to be at-risk are then referred for invasive amniocentesis, which comes with a chance of miscarriage.